TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scanfarma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
899
|
933
|
1,141 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
68
|
50
|
-18 |
| EBITDA |
65
|
50
|
-18 |
| Total assets |
677
|
719
|
737 |
| Current assets |
654
|
719
|
737 |
| Current liabilities |
79
|
131
|
140 |
| Equity capital |
415
|
371
|
359 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
5
|
6
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
61.3%
|
51.6%
|
48.7% |
| Turnover per employee |
180
|
156
|
163 |
| Profit as a percentage of turnover |
7.6%
|
5.4%
|
-1.6% |
| Return on assets (ROA) |
10.2%
|
7.0%
|
-2.4% |
| Current ratio |
827.8%
|
548.9%
|
526.4% |
| Return on equity (ROE) |
16.4%
|
13.5%
|
-5.0% |
| Change turnover |
-36
|
-115
|
-46 |
| Change turnover % |
-4%
|
-11%
|
-4% |
| Chg. No. of employees |
-1
|
-1
|
-1 |
| Chg. No. of employees % |
-17%
|
-14%
|
-13% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.